Enhancing CAR-T Therapy in CLL By Modulating the Immunosuppressive Tumor Microenvironment: A Novel Approach with Significant Therapeutic Potential

被引：0
|
作者：
Palma, Angimar Uriepero [1 ]
Uarela, Melanie Mediavilla [2 ]
Marquez, Maria Elena [3 ]
Gamal, Wael [2 ]
Ammad-ud-din, Mohammad [4 ]
Oppezzo, Pablo [5 ]
Sahakian, Eva [6 ]
Pinilla-Ibarz, Javier [7 ]
机构：
[1] Jefferson Einstein Hosp, Dept Internal Med, Philadelphia, PA USA
[2] H Lee Moffitt Canc Ctr & Res Inst, Immunol Immune Oncol, Tampa, FL USA
[3] Inst Pasteur Montevi, Res Lab Chron Lymphocyt Leukemia, Montevideo, Uruguay
[4] H Lee Moffitt Canc Ctr & Res Inst, Dept Hematol Oncol, Tampa, FL USA
[5] Inst Pasteur Montevideo, Montevideo, Uruguay
[6] H Lee Moffitt Canc Ctr & Res Inst, Dept Immunol, Tampa, FL USA
[7] H Lee Moffitt Canc Ctr & Res Inst, Malignant Hematol, Tampa, FL USA
来源：
BLOOD | 2024年 / 144卷
关键词：
D O I：
10.1182/blood-2024-204892
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：4607 / 4608
页数：2
相关论文
共 50 条
  • [41] Armoring CAR-T therapy with PD-1 blockade: a powerful strategy for enhancing anti-tumor effects in pancreatic cancer
    Zhang, Zhixiang
    Huang, Jingwei
    Zhao, Zhifeng
    Wang, Xiangyi
    He, Cnhui
    Yang, Sen
    Gu, Qingyang
    CANCER RESEARCH, 2024, 84 (06)
  • [42] Enhancing CAR-T cell therapy against solid tumor by drug-free triboelectric immunotherapy (Vol 314, 122871, 2025)
    Li, Haimei
    Wang, Zichen
    Hu, Yulin
    He, Guangqin
    Huang, Liang
    Liu, Yi
    Wang, Zhong Lin
    Jiang, Peng
    BIOMATERIALS, 2025, 315
  • [43] Locoregional GPC3 chimeric antigen receptor ( CAR)-T cell therapy is associated with improved tumor control in hepatocellular carcinoma by enhancing CAR-T cell trafficking and functionality
    Wang, Jue
    Tsang, Kinching
    Qiu, Jiale
    Feng, Bo
    CANCER RESEARCH, 2024, 84 (06)
  • [44] CB-012, an allogeneic anti-CLL-1 CAR-T cell therapy engineered with next-generation CRISPR technology to resist both the immunosuppressive tumor microenvironment and immune cell-mediated rejection, for patients with relapsed or refractory acute myeloid leukemia
    Garner, Elizabeth
    Kelly, Erin
    Namburi, Sai
    Colgan, Cian
    Fowler, Tristan
    Mutha, Devin
    Aviles, Art
    Stanaway, Morena
    Guo, Raymond
    An, Zili
    Degagne, Emilie
    Kwong, George
    Edwards, Leslie
    Jakes, Emma
    Shaw, Mckay
    Schilling, Benjamin
    Huynh, Jeremy
    Luu, Ricky
    Sidorov, Max
    Mousali, Rhonda
    Otsmaa, Mikk
    Skoble, Justin
    Kanner, Steven
    CANCER RESEARCH, 2023, 83 (07)
  • [45] A novel CAR-T cell product targeting CD74 is an effective therapeutic approach in preclinical mantle cell lymphoma models
    Wing Keung Chan
    Jessica Williams
    Kinnari Sorathia
    Betsy Pray
    Kaled Abusaleh
    Zehua Bian
    Archisha Sharma
    Ian Hout
    Shamama Nishat
    Walter Hanel
    Shelby L. Sloan
    Aneeq Yasin
    Nathan Denlinger
    Xiaoli Zhang
    Natarajan Muthusamy
    Sumithira Vasu
    Marcos de Lima
    Yiping Yang
    Robert Baiocchi
    Lapo Alinari
    Experimental Hematology & Oncology, 12
  • [46] A novel CAR-T cell product targeting CD74 is an effective therapeutic approach in preclinical mantle cell lymphoma models
    Chan, Wing Keung
    Williams, Jessica
    Sorathia, Kinnari
    Pray, Betsy
    Abusaleh, Kaled
    Bian, Zehua
    Sharma, Archisha
    Hout, Ian
    Nishat, Shamama
    Hanel, Walter
    Sloan, Shelby L.
    Yasin, Aneeq
    Denlinger, Nathan
    Zhang, Xiaoli
    Muthusamy, Natarajan
    Vasu, Sumithira
    de Lima, Marcos
    Yang, Yiping
    Baiocchi, Robert
    Alinari, Lapo
    EXPERIMENTAL HEMATOLOGY & ONCOLOGY, 2023, 12 (01)
  • [47] 18F-FDG PET/CT metrics-based stratification of large B-cell lymphoma receiving CAR-T cell therapy: immunosuppressive tumor microenvironment as a negative prognostic indicator in patients with high tumor burden
    Sheng, Ling-Shuang
    Shen, Rong
    Yan, Zi-Xun
    Wang, Chao
    Zheng, Xin
    Zhang, Yi-Lun
    Yang, Hao-Xu
    Wu, Wen
    Xu, Peng-Peng
    Cheng, Shu
    Bachy, Emmanuel
    Sesques, Pierre
    Jacquet-Francillon, Nicolas
    Jiang, Xu-Feng
    Zhao, Wei-Li
    Wang, Li
    BIOMARKER RESEARCH, 2024, 12 (01)
  • [48] A novel approach and model to limit cytokine release syndrome and off-tumor toxicity of synthetically enhanced CEA CAR-T cells
    Bartlett, Alexandra
    Eil, Robert M. D.
    CANCER IMMUNOLOGY RESEARCH, 2024, 12 (10)
  • [49] Harnessing the potential of CAR-T cell therapy: progress, challenges, and future directions in hematological and solid tumor treatments (vol 41, 449, 2023)
    Dagar, Gunjan
    Gupta, Ashna
    Masoodi, Tariq
    Nisar, Sabah
    Merhi, Maysaloun
    Hashem, Sheema
    Chauhan, Ravi
    Dagar, Manisha
    Mirza, Sameer
    Bagga, Puneet
    Kumar, Rakesh
    Akil, Ammira S. Al-Shabeeb
    Macha, Muzafar A.
    Haris, Mohammad
    Uddin, Shahab
    Singh, Mayank
    Bhat, Ajaz A.
    JOURNAL OF TRANSLATIONAL MEDICINE, 2023, 21 (01)
  • [50] Ghost Cytometry as a Novel Approach for Label-Free Evaluation and Sorting in the Manufacturing of CAR-T Cells and Other Cell Therapy Products
    Wagatsuma, Keisuke
    Tamoto, Ryo
    Adachi, Hiroaki
    Teranishi, Kazuki
    Akai, Satoru
    Matsuyama, Kaori
    Ota, Sadao
    MOLECULAR THERAPY, 2022, 30 (04) : 361 - 362
12345